Back to results
US 7,064,202 B1Granted
Camptothecin intermediates and prodrugs and methods of preparation thereof
AssigneesUniversity of Kentucky Research Foundation, University of Pittsburgh
InventorsThomas G. Burke, deceased, Dennis P. Curran, Wu Du
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel intermediates and prodrugs of camptothecin and related analogs.
Claims2
A compound with the formula:
- where R1 may be:
- a) hydrogen, a halogen atom, a branched or linear alkyl group, a branched or linear alkenyl group, a branched or linear alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, an alkylamino group, a dialkylamino group, an alkylthiol group, a thiol group, a phenyl group, an amino group, a nitro group, a cyano group;
- b) a (CH2)YNR8R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R2 may be:
- a) hydrogen, a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, a linear or branched alkynyl group, an amino group, an alkylamino group, a dialkylamino group, a nitro group, a 3–10 membered heterocyclic ring, a C3-10 cycloalkyl group, a C3-10 cycloalkenyl group, a C8-10 cycloalkynyl group, a thiol group, a cyano group;
- b) a (CH2)YNR8 R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R3 may be:
- a) hydrogen, a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, a linear or branched alkynyl group, an amino group, an alkylamino group, a dialkylamino group, a nitro group, a C3-10 cycloalkyl group, a C3-10 cycloalkenyl group, a C8-10 cycloalkynyl group, a thiol group, a cyano group, a hydroxyl group;
- b) a (CH2)YNR8R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R4 may be hydrogen, a halogen atom, a hydroxy group, an amino group, a methoxy group, an alkyl group, an alkynyl group or an alkenyl group;
- R5 may be hydrogen or fluorine;
- R6 may be an alkyl group, an alkenyl group, an alkynyl group, or a benzyl group;
- R7 may be hydrogen, an alkyl group, an alkenyl group, an alkynyl group, a benzyl group, an alkoxy group, an aryloxy group, or an acyloxy group;
- and pharmaceutically acceptable salts thereof.
11 more elements
A compound with the formula:
- where R1 may be:
- a) hydrogen, a halogen atom, a branched or linear alkyl group, a branched or linear alkenyl group, a branched or linear alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, an alkylamino group, a dialkylamino group, an alkylthiol group, a thiol group, a phenyl group, an amino group, a nitro group, a cyano group;
- b) a (CH2)YNR8R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R2 may be:
- a) hydrogen, a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, a linear or branched alkynyl group, an amino group, an alkylamino group, a dialkylamino group, a nitro group, a 3–10 membered heterocyclic ring, a C3-10 cycloalkyl group, a C3-10 cycloalkenyl group, a C8-10 cycloalkynyl group, a thiol group, a cyano group;
- b) a (CH2)YNR8R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R3 may be:
- a) hydrogen, a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, a linear or branched alkynyl group, an amino group, an alkylamino group, a dialkylamino group, a nitro group, a 3–10 membered heterocyclic ring, a C3-10 cycloalkyl group, a C3-10 cycloalkenyl group, a C8-10 cycloalkynyl group, a thiol group, a cyano group, a hydroxyl group;
- b) a (CH2)YNR8R9 group, wherein Y is an integer from 1–10 and R8 and R9 are, independently, hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an amine, an alkyl amine, a dialkyl amine, a hydroxy group, an alkoxy group, an acyl group, a carbamate;
- R4 may be hydrogen, a halogen atom, a hydroxy group, an amino group, a methoxy group, an alkyl group, an alkynyl group or an alkenyl group;
- R5 may be hydrogen or fluorine;
- R6 may be an alkyl group, an alkenyl group, an alkynyl group, a benzyl group, an alkoxy group, an aryloxy group, or an acyloxy group;
- R7 may be hydrogen, an alkyl group, an alkenyl group, a benzyl group, an alkoxy group, an aryloxy group, or an acyloxy group;
- and
- R8 may be hydrogen, an alkyl group, or an alkenyl group;
- and
- pharmaceutically acceptable salts thereof.
14 more elements
Dependencies are inferred from the claim text.